Orrin M Troum, M.D. and Medical Associates

Quick facts

Phase 2 pipeline

• Subcutaneous Abatacept

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Orrin M Troum, M.D. and Medical Associates portfolio CI brief
• Orrin M Troum, M.D. and Medical Associates pipeline updates RSS

Related

• Sector hub: All tracked pharma companies